Dexlansoprazole
15 NDCs across 5 manufacturers|12 Generic,3 Brand
Dexlansoprazole is used to treat peptic esophagitis, gastroesophageal reflux and heartburn, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 30, 2009, and the first generic was approved Apr 19, 2017. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $262 million on Dexlansoprazole across 883,000 claims for 196,000 beneficiaries.
Dexlansoprazole is available as 15 NDCs from 5 manufacturers (12 generic, 3 brand), with NADAC prices from $3.66 to $9.85 per EA — the most expensive product costs about 2.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
15
12G / 3B
Manufacturers
5
competing in market
Price Spread
$3.66 – $9.85
per EA
7d Activity
avg -1.3% WoW · of 15 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
5 manufacturers producing DEXLANSOPRAZOLE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DEXILANT DR 30 MG CAPSULE | $9.8514 per EA | +0.09% |
DEXILANT DR 60 MG CAPSULE | $9.8408 per EA | -0.01% |
DEXILANT DR 60 MG CAPSULE | $9.8408 per EA | -0.01% |
DEXLANSOPRAZOLE DR 30 MG CAP | $3.9664 per EA | -3.52% |
DEXLANSOPRAZOLE DR 30 MG CAP | $3.9664 per EA | -3.52% |
DEXLANSOPRAZOLE DR 30 MG CAP | $3.9664 per EA | -3.52% |
DEXLANSOPRAZOLE DR 30 MG CAP | $3.9664 per EA | -3.52% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.6568 per EA | -0.71% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.6568 per EA | -0.71% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.6568 per EA | -0.71% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.6568 per EA | -0.71% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.6568 per EA | -0.71% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.6568 per EA | -0.71% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.6568 per EA | -0.71% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.6568 per EA | -0.71% |
Frequently Asked Questions
What is Dexlansoprazole used to treat?
Dexlansoprazole is used to treat peptic esophagitis, gastroesophageal reflux and heartburn, per the National Library of Medicine's MED-RT classification.
When did Dexlansoprazole become available as a generic?
FDA approved the first generic Dexlansoprazole (ANDA) on Apr 19, 2017. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dexlansoprazole?
In 2024, Medicare Part D spent $262 million on Dexlansoprazole across 883,000 claims for 196,000 beneficiaries.
How many Dexlansoprazole products are on the market?
The Dexlansoprazole drug market contains 15 NDCs from 5 manufacturers — 12 generic and 3 brand products.
What is the price range for Dexlansoprazole?
NADAC reference prices for Dexlansoprazole range from $3.6568 to $9.8514 per EA — the most expensive product costs about 2.7× the cheapest.
Is generic Dexlansoprazole cheaper than brand?
The average generic NADAC for Dexlansoprazole is $3.7600 per EA, versus $9.8443 for brand-labeled products — brand versions average about 2.6× the generic price.
Which manufacturers make Dexlansoprazole?
5 manufacturers list Dexlansoprazole in NADAC. Ranked by number of NDCs, the largest are Takeda Pharmaceuticals America, Inc. (3), Mylan Pharmaceuticals Inc. (3), Upsher-Smith Laboratories LLC (3), Endo USA Inc. (3), Alembic Pharmaceuticals Inc. (3).
How has the price of Dexlansoprazole changed recently?
Over the past 7 days, 1 Dexlansoprazole NDC rose and 14 fell, with a market-wide average change of -1.3%.